JPMorgan Funds - Thematics - Genetic Therapies I2 Fonds
60,51
USD
-1,09
USD
-1,77
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Novartis AG Registered Shares | CH0012005267 | 3,21% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,14% |
| PTC Therapeutics Inc | US69366J2006 | 3,13% |
| Astellas Pharma Inc | JP3942400007 | 2,97% |
| Krystal Biotech Inc | US5011471027 | 2,96% |
| Amgen Inc | US0311621009 | 2,96% |
| Gilead Sciences Inc | US3755581036 | 2,94% |
| Biomarin Pharmaceutical Inc | US09061G1013 | 2,84% |
| Bristol-Myers Squibb Co | US1101221083 | 2,72% |
| Lonza Group Ltd | CH0013841017 | 2,67% |
| Sonstige | 70,45% |